Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultra-low Dose Transdermal Estradiol Therapy in Prepubertal Girls With Turner Syndrome and Primary Ovarian Insufficiency.

NCT07784582 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.

NCT NCT07784582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07784582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultra-low Dose Transdermal Estradiol Therapy in Prepubertal Girls With Turner Syndrome and Primary Ovarian Insufficiency.
Lead sponsor
Children's National Research Institute
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
June 30, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary ovarian insufficiency, turner syndrome